Compare TTD & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTD | MEDP |
|---|---|---|
| Founded | 2009 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 15.4B |
| IPO Year | 2016 | 2016 |
| Metric | TTD | MEDP |
|---|---|---|
| Price | $17.95 | $592.77 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 34 | 12 |
| Target Price | $46.22 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 12.8M | 353.5K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 15.38 | ★ 20.98 |
| EPS | 0.08 | ★ 8.53 |
| Revenue | ★ $2,896,284,000.00 | N/A |
| Revenue This Year | $13.94 | $13.19 |
| Revenue Next Year | $12.61 | $7.75 |
| P/E Ratio | $216.13 | ★ $70.50 |
| Revenue Growth | ★ 18.47 | N/A |
| 52 Week Low | $16.70 | $373.00 |
| 52 Week High | $91.45 | $677.90 |
| Indicator | TTD | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 46.17 | 71.47 |
| Support Level | $16.98 | $577.01 |
| Resistance Level | $20.54 | $622.32 |
| Average True Range (ATR) | 0.83 | 20.72 |
| MACD | -0.09 | 4.15 |
| Stochastic Oscillator | 41.07 | 50.47 |
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. The firm's platform is referred to as a DSP in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising, sometimes referred to as a "take rate".
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.